Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia

Br J Haematol. 2020 Feb;188(4):e49-e53. doi: 10.1111/bjh.16320. Epub 2019 Dec 18.

¹ TIMM Laboratory, Sahlgrenska Cancer Center, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
² Department of Haematology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
³ Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁴ Department of Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden.

No abstract available

Keywords: IL-2; aml; chemotherapy; histamine dihydrochloride; immunotherapy.

Publication types